Netrin-1 Blockade Inhibits Tumor Associated Myeloid-Derived Suppressor Cells and Cancer Stemness and Alleviates Resistance to Chemotherapy and Immune Checkpoint Inhibitor

Scientists showed that netrin-1 was an independent prognostic marker for clinical progression of breast and ovary cancers. They found a significant correlation between netrin-1 expression and CSC markers levels.